*  Dyslipidemia | Lipid Disorders - Levels, Symptoms, Signs, Diagnosis, Treatment and Prevention
Find out more about dyslipidemia, its causes and methods to treat the condition. ... Dyslipidemia is a condition due to imbalance of fats in blood. ... How do you Treat Dyslipidemia?. The treatment of Dyslipidemia ... How to Prevent Dyslipidemia?. It is important to take steps to prevent Dyslipidemia as it is a means of lowering the risk for a ... What are the Causes for Dyslipidemia?. There are many factors for Dyslipidemia and they include:. *Genetic or Hereditary ...
  http://www.medindia.net/patients/patientinfo/dyslipidemia.htm
*  Secondary causes of dyslipidemia
The secondary causes of dyslipidemia will be reviewed briefly here ().Primary lipid disorders are discussed separately ... Dyslipidemia due to secondary causes is common. In a cohort of 824 new patients referred to a lipid clinic at an academic ... Secondary causes of dyslipidemia. Am J Cardiol 2012; 110:823.. *Zavaroni I, Dall'Aglio E, Alpi O, et al. Evidence for an ... Secondary causes of dyslipidemia. Author. Robert S Rosenson, MD. Robert S Rosenson, MD ...
  https://www.uptodate.com/contents/secondary-causes-of-dyslipidemia
*  Plus it
Insulin Resistance, Dyslipidemia, and Cardiovascular Disease Message Subject (Your Name) has forwarded a page to you from ... Insulin resistance and dyslipidemia. Ronald Krauss (San Francisco, CA) gave insights in the genetics of the more common forms ... Krauss RM: Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 25:2265-2272, 2005. ... There is an intimate relationship between diet and dyslipidemia, and dietary manipulations may be used to understand the ...
  http://care.diabetesjournals.org/content/30/8/2164
*  The Johns Hopkins Textbook of Dyslipidemia | Circulation
Management of dyslipidemia has become a mainstay of routine clinical practice for both hospital specialists and those involved ... A problem with the book is the relatively small section devoted to a discussion of the drug treatment of dyslipidemia. Chapter ... The Johns Hopkins Textbook of Dyslipidemia 303 pages. Philadelphia, USA: Lippincott Willams and Wilkins, 2010. $99.95. ISBN 0- ... Textbooks in the area of dyslipidemia tend to be of 2 main types: relatively brief handbooks that focus on clinical management ...
  http://circ.ahajournals.org/content/122/20/e517
*  Causes and Natural History of Dyslipidemias - No Study Results Posted - ClinicalTrials.gov
Causes and Natural History of Dyslipidemias. The safety and scientific validity of this study is the responsibility of the ...
  https://clinicaltrials.gov/ct2/show/results/NCT00353782
*  Quiz: Dyslipidemia - Merck Manuals Professional Edition
Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual in the remainder of the world. Learn more about our commitment to Global Medical Knowledge.. ...
  http://www.merckmanuals.com/en-ca/professional/multimedia/quiz/17
*  K/DOQI To Examine Dyslipidemias In Transplant Patients - The National Kidney Foundation
... professionals will conduct an extensive structured review of the literature related to cardiovascular disease and dyslipidemias ... The relationship between dyslipidemias and cardiovascular disease has been best studied in kidney transplant recipients. ... The effort will encompass recommendations on hypertension, left ventricular hypertrophy and dyslipidemias. ... professionals will conduct an extensive structured review of the literature related to cardiovascular disease and dyslipidemias ...
  https://www.kidney.org/news/newsroom/newsreleases/0172
*  South African Dyslipidaemia Guideline Consensus Statement
8. Management of dyslipidaemia. Because the total cardiovascular risk is the product of a number of risk factors, the treatment ... Dyslipidaemia may occur in response to another condition or treatment. Table 2 lists those encountered most commonly. The ... Dyslipidaemia frequently accompanies HIV and may be aggravated by ARVs. While there is limited information, particularly in ... Intensive management of dyslipidaemia in South Africa will significantly reduce the cardiovascular disease health burden. ...
  http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742012000300032&lng=en&nrm=iso&tlng=en
*  South African Dyslipidaemia Guideline Consensus Statement
... SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.3, pp.177-187. ISSN ... Intensive management of dyslipidaemia in South Africa will significantly reduce the cardiovascular disease health burden. ... The European Society of Cardiology together with the European Atherosclerosis Society published updated dyslipidaemia ...
  http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S0256-95742012000300032&lng=es&nrm=iso&tlng=en
*  Prevalence of Dyslipidemia in Patients Receiving Health Checkups: A Hospital-Based Study
Prevalence of Dyslipidemia in Patients Receiving Health Checkups: A Hospital-Based Study. Kao-Chi Cheng,1,2 Yu-Lung Chen,1,2 ... That is, the prevalence of dyslipidemia in women is lower in the group aged 20-39 than in the group aged 40 and over, but no ... K. Tziomalos, V. G. Athyros, A. Karagiannis, and D. P. Mikhailidis, "Dyslipidemia as a risk factor for ischemic stroke," ... We used the dataset from one medical center in Taiwan to explore the prevalence of dyslipidemia, which included 2695 subjects ...
  https://www.hindawi.com/journals/cholesterol/2011/314234/
*  Dyslipidemia is common after spinal cord injury - independent of clinical measures
... Flank, Peter UmeƄ University, Faculty of ... Results: Eighty-one percent of all patients had dyslipidemia (DL) and a majority of the patients with abdominal measures below ... Eighty-one percent of the patients had dyslipidemia, where also a majority of the patients with normal abdominal clinical ... Dyslipidemia was common for both men and women at all BMI categories. The study also showed a high prevalence of hypertension, ...
  http://www.diva-portal.org/smash/record.jsf?pid=diva2:913733
*  Effects of a multicomponent wellness intervention on dyslipidemia among overweight adolescents | RTI
... and strength training on dyslipidemia in nine overweight/obese [body mass index (BMI) ,= 85th percentile] and nine lean (BMI ... Behavioral changes are the first line of treatment for dyslipidemia in adolescents, but outcome data on the effectiveness of ... Behavioral changes are the first line of treatment for dyslipidemia in adolescents, but outcome data on the effectiveness of ... and strength training on dyslipidemia in nine overweight/obese [body mass index (BMI) ,= 85th percentile] and nine lean (BMI , ...
  https://www.rti.org/publication/effects-multicomponent-wellness-intervention-dyslipidemia-among-overweight-adolescents
*  Dyslipidemia Study Investigating The Increase In 'Good Cholesterol' - Full Text View - ClinicalTrials.gov
Dyslipidemia Study Investigating The Increase In 'Good Cholesterol'. The safety and scientific validity of this study is the ... Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Fenofibrate. Hypolipidemic Agents. Antimetabolites. Molecular ...
  https://clinicaltrials.gov/ct2/show/NCT00169559
*  Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation
B. L. Kasiske, A. de Mattos, S. M. Flechner et al., "Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant ... L. V. Riella, S. Gabardi, and A. Chandraker, "Dyslipidemia and its therapeutic challenges in renal transplantation," American ... B. Kasiske, F. G. Cosio, J. Beto et al., "Clinical practice guidelines for managing dyslipidemias in kidney transplant patients ... Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation. Kazuyuki ...
  https://www.hindawi.com/journals/dm/2015/179434/ref/
*  Dyslipidemia Drugs Market Size | Industry Report,2023
The dyslipidemia drugs market promises lucrative growth opportunities for pharmaceutical manufacturers due to increasing demand ... Global Dyslipidemia Drugs Market: Trends and Opportunities The global market for dyslipidemia drugs is projected to gain ... Global Dyslipidemia Drugs Market: Overview With a sudden rise in the expiration of blockbuster drugs, the global market for ... The Europe dyslipidemia drugs market is expected to witness a relatively low decline (at a CAGR of -9.9%) over the forecast ...
  https://www.transparencymarketresearch.com/dyslipidemia-market.html
*  Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects - Full Text View -...
Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects. The safety and scientific ... Dyslipidemias. Glucose Metabolism Disorders. Metabolic Diseases. Endocrine System Diseases. Pathologic Processes. Lipid ... Atherogenic dyslipidemia by measuring plasma lipids and lipoprotein mean size and subfractions by nuclear magnetic resonance. ... Egg Effects on Atherogenic Dyslipidemia, Glucose Metabolism and Inflammation in Diabetic Subjects. ...
  https://clinicaltrials.gov/ct2/show/NCT02181244
*  Chronic Kidney Disease: Cardiovascular Disease and Dyslipidemia - Renal and Urology News
Screening for dyslipidemia with a fasting lipid profile in patients with CKD is routinely recommended. However, the typical ... Dyslipidemia. The evidence between serum cholesterol and development of atherosclerotic disease in the general population is ... dyslipidemia. CKD: lipid-lowering therapy guidelines as extrapolated from the general population (stages 1 - 4 CKD)ESRD: ... Once remedial secondary causes of dyslipidemia have been excluded, the decision to initiate lipid lowering therapy should be ...
  http://www.renalandurologynews.com/nephrology-hypertension/chronic-kidney-disease-cardiovascular-disease-and-dyslipidemia/article/615863/
*  Dyslipidemia - Ragavendra R. Baliga; Christopher P. Cannon - Oxford University Press
Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid ... You are here: Home Page , Medicine & Health , Clinical Medicine , Cardiovascular Medicine , Dyslipidemia ... Dyslipidemia. Edited by Ragavendra R. Baliga and Christopher P. Cannon. Oxford American Cardiology Library. *Authored by a ... Dyslipidemia. Edited by Ragavendra R. Baliga and Christopher P. Cannon. Oxford American Cardiology Library. ...
  https://global.oup.com/academic/product/dyslipidemia-9780199742868?cc=ca&lang=en
*  Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
... Ladenson, Paul W Johns Hopkins University. ... BACKGROUND Dyslipidemia increases the risk of atherosclerotic cardiovascular disease and is incompletely reversed by statin ...
  http://liu.diva-portal.org/smash/record.jsf?pid=diva2:304602
*  Plus it
Management of combined dyslipidemia is of utmost importance in these populations because these conditions are associated with a ... The effect of ezetimibe on other dyslipidemias, particularly hypertriglyceridemia, is not yet known. In the present studies, we ... American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 22 (Suppl ... In conclusion, ezetimibe is very effective in correcting the combined dyslipidemia in diet-induced obese hyperinsulinemic ...
  http://diabetes.diabetesjournals.org/content/50/6/1330
*  Sabinet | Rational use of lipid investigations : more about... dyslipidaemia
Dyslipidaemia is a common and an important problem. It accounts for almost 50% of the population-attributable risk of ... n CME : Your SA Journal of CPD - Rational use of lipid investigations : more about... dyslipidaemia * Navigate this Journal ... Dyslipidaemia is a common and an important problem. It accounts for almost 50% of the population-attributable risk of ...
  http://journals.co.za/content/m_cme/27/3/EJC63626
*  Screening for and Managing Dyslipidemia in People With HIV - TheBodyPRO.com
Table 4. Selected Trials of Niacin and/or Fibrate for Dyslipidemia in People With HIV. ... Will PCSK9 inhibitors have a role in HIV dyslipidemia?. The PCSK9 inhibitors alirocumab (Praluent) and evolocumab (Repatha) ... Table 6. Selected Trials of Fish Oils for Dyslipidemia in People With HIV. ... Table 5. Selected Trials of Ezetimibe for Dyslipidemia in People With HIV. ...
  http://www.thebodypro.com/content/79781/screening-for-and-managing-dyslipidemia-in-people-.html?getPage=2
*  Abstract 16850: Effect of Alirocumab in Patients With Diabetic Dyslipidemia and Chronic Kidney Disease | Circulation
Abstract 16850: Effect of Alirocumab in Patients With Diabetic Dyslipidemia and Chronic Kidney Disease. Jamie P Dwyer, Helen M ... Conclusion: ALI was an effective and well-tolerated treatment for dyslipidemia in T2DM patients; no effect on CKD progression ... Introduction: Patients with type 2 diabetes mellitus (T2DM) are predisposed to dyslipidemia and chronic kidney disease (CKD), ... Abstract 16850: Effect of Alirocumab in Patients With Diabetic Dyslipidemia and Chronic Kidney Disease ...
  http://circ.ahajournals.org/content/134/Suppl_1/A16850
*  Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds
Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents with HIV: the PositHIVe Health ... Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds. ...
  http://www.ajmc.com/newsroom/chronic-inflammation-dyslipidemia-puts-children-teens-with-hiv-at-higher-cv-risk-study-finds